AiCure

About:

AiCure is an advanced data analytics company that uses artificial intelligence to understand how patients respond to treatments.

Website: http://www.aicure.com

Twitter/X: AiCureMed

Top Investors: Baird Capital, Accelmed, Asahi Kasei, Singtel Innov8, Tribeca Venture Partners

Description:

AiCure is an advanced data analytics company that uses artificial intelligence to understand how patients respond to treatments. It enables intelligent decision-making and improving health outcomes. It has developed patented facial recognition and motion-sensing technology to confirm medication ingestion in real-time. AiCure's platform has the potential to revolutionize the cost-effectiveness of healthcare delivery systems by enhancing treatment and reducing risks. Their software captures and understands video, audio, and behavioral data to establish the link between patients, disease, and treatment. It was founded in 2010 and is headquartered in New York.

Total Funding Amount:

$68.8M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

New York, New York, United States

Founded Date:

2009-12-01

Contact Email:

info(AT)aicure.com

Founders:

Adam Hanina, Laura Shafner

Number of Employees:

101-250

Last Funding Date:

2024-01-23

IPO Status:

Private

© 2024 MyAiNote.com